Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Vaccine Delivery Devices Market Size Worth $6.21 Billion by 2025: Grand View Research, Inc.

Grand View Research
Posted on: 25 Jul 17

SAN FRANCISCO, July 25, 2017 /PRNewswire/ --

The global vaccine delivery devices market is expected to reach USD 6.21 billion by 2025, according to a new report by Grand View Research, Inc. The market is primarily driven by growing immunization programs, financial support from government & nongovernment organizations, increasing vaccination initiatives & campaigns, and rising prevalence of infectious diseases globally. Growing research in the field of vaccines and development of new products is also contributing to the growth of the market.

Adoption of needle-free approach for administering these products is gaining momentum due to growing awareness and demand to avoid pain & injuries associated with the use of a needle stick. Data by the Centers for Disease Control and Prevention states that an estimated 385,000 sharp injuries including needle stick injuries occur every year in hospitals in the U.S. Advancing technologies in administering vaccines and their increasing adoption is propelling market growth. Rising interest of various key players, national institutions, and organizations in novel delivery technologies is expected to further contribute to market growth.

Various governments and international organizations are increasingly investing in the development of vaccination programs. For instance, the UK government also announced funding up to £1 million from its Global Challenges Research Fund through Medical Research Council to investigate the Zika virus and its transmission. Organizations such as GAVI Alliance, Bill & Melinda Gates Foundation, Path, and WHO are actively involved in the field of vaccines. Many governments are also undertaking several immunization programs on priority.

Browse full research report with TOC on "Vaccine Delivery Devices Market Analysis By Devices (Syringes, Jet Injectors, Other Devices), By Route of Administration (Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination, Others), And Segment Forecasts, 2014 - 2025" at: http://www.grandviewresearch.com/industry-analysis/vaccine-delivery-devices-market

Further key findings from the report suggest: 

The syringes segment held majority of the revenue share in 2016 due to increasing vaccination programs, spreading immunization coverage, and technological advancements

Jet injectors is expected to register highest growth during the forecast period owing to rising concerns regarding needle stick injuries and growing preference for needle-free technologies

Intramuscular vaccination dominated the route of administration segment in 2016 as majority of vaccines are given through this route owing to its advantages

North America dominated the global market owing to increasing awareness levels, high adoption of technology, and rising prevalence of infectious diseases

Some of the key players include Becton Dickinson & Company, Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.); Gerresheimer AG; PharmaJet; Corium International, Inc.; and SCHOTT AG

Browse related reports by Grand View Research: 

Fluid Management Systems Market - http://www.grandviewresearch.com/industry-analysis/fluid-management-systems-market

Kidney Fibrosis Treatment Market - http://www.grandviewresearch.com/industry-analysis/kidney-fibrosis-treatment-market

Gastrointestinal Endoscopic Devices Market- http://www.grandviewresearch.com/industry-analysis/gastrointestinal-endoscopic-devices-market

Acute Coronary Syndrome Market- http://www.grandviewresearch.com/industry-analysis/acute-coronary-syndrome-market

Grand View Research has segmented the vaccine delivery devices market on the basis of devices, route of administration, and region: 

Devices Outlook (Revenue, USD Million, 2014 - 2025) 

Syringes

Jet Injectors

Other Devices

Route of Administration Outlook (Revenue, USD Million, 2014 - 2025) 

Intradermal Vaccination

Intramuscular vaccination

Subcutaneous Vaccination

Other Vaccinations

Regional Outlook (Revenue, USD Million, 2014 - 2025) North America

U.S.

Canada

Europe

Germany

UK

Asia Pacific

China

Japan

Latin America

Brazil

Mexico

Middle East & Africa

South Africa

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Read Our Blogs -grandviewresearch.com/blogs/healthcare

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com

Web: http://www.grandviewresearch.com  

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 25/07/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.